A popular milk alternative for those with dairy sensitivity and lactose intolerance is being recalled in more than two dozen states. HP Hood LLC is recalling multiple units of its 96-ounce Lactaid ...
Elahere was found to improve survival in patients with FR-alpha–positive, platinum-resistant, high-grade serous epithelial ...
FDA drug alerts in pulmonology, including drug approvals/warnings, vaccine approvals, medical device recalls/updates, and ...
Elahere, which won initial U.S. Food and Drug Administration approval in 2022 for platinum-resistant ovarian cancer, was the key asset in AbbVie's $10.1 billion acquisition of biotech ImmunoGen that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback